In this study, we described the condition of the musculoskeletal organs in patients undergoing TKA by the LS risk test and evaluated the changes afforded by the surgery. Our data clearly showed that most of the patients belonged to locomotive syndrome stage 2 or 3 pre-operatively (98.4%), and TKA improved their condition in terms of patient-oriented outcome measures and objective function tests.
A recent report on the reference values of the LS risk test in a healthy population showed that the median GLFS-25 scores for those aged between 65 and 69, and 75 and 79 were 4 and 6, respectively [10]. On the other hand, Yamada et al. reported that the mean GLFS-25 score for the elderly who availed the services of the LTCI system was 33.8 [9]. In our study, the average preoperative GLFS-25 score was 38.3 suggesting that the pre-operative condition of patients undergoing TKA was similar to the condition of individuals who need care and support and have a risk of dependency. The significant improvement in the GLFS-25 and other tests after TKA confirmed that joint replacement surgeries have a beneficial impact not only on knee pain and function but also on the improvement of general musculoskeletal function.
The selection of the optimal age is critical for successful surgeries [27, 28]. Our study showed that the degree of improvement provided by TKA is equivalent between the older (≥ 75 years) and younger (64–74 years) age groups, suggesting that surgery is expected to improve the ability to perform daily activities even in older patients. However, it should be noted that the pre- and post-operative GLFS-25 scores were higher in the older age group than that of the younger age group (mean post-operative GLFS-25 score, ≥ 75 age group, 21.8 ± 19.4 vs. 60–74 age group, 16.0 ± 13.5). As the number of people using the LTCI services increases after the age of 75, the residual dysfunction and difficulty in daily activities among the older age group patients should be carefully monitored so that their physical condition can be maintained through suitable lifestyle modifications and if necessary, treatments.
One of the advantages of the LS risk test is its ability to evaluate the condition of the musculoskeletal organs in an integrated manner. In our study, 48.1% of patients had moderate or severe pain in sites other than the leg, suggesting that the patients suffered not only from KOA but also from other musculoskeletal disorders such as degenerative spinal disorders and upper limb pain. As previously reported, many patients tend to have multiple bone and joint diseases, and the difficulties faced by them in daily life reflect the summation of all these symptoms [11, 29, 30]. Using the LS risk test, the physician can gauge the overall impact of the disease on patients’ daily living and the function of their locomotive organs. The integrated difficulties in the daily living of patients with multiple musculoskeletal problems have been evaluated using various quality of life assessment scales such as EQ-5D, a well-established scale that consists of five questionnaires, assessing the mobility, self-care, activity, pain, and anxiety [31]. Because Seichi et al. reported that the GLFS-25 score correlated well with the EQ-5D score, the GLFS-25 has a potential to be used as a quality of life outcome measure for patients with musculoskeletal diseases as demonstrated in the current study where the two scales showed similar trends [6]. While the LS risk test questionnaire form takes longer to complete which is a disadvantage, its wide range of scores provides sufficient sensitivity to detect changes during longitudinal observation. Therefore, the LS risk test would be useful for a long-term follow-up analysis in patients undergoing conservative treatment and/or musculoskeletal surgeries in organs other than the knee joints. In future, the data accumulated from the LS risk test during the long-term follow-up will help physicians develop therapeutic strategies for managing the mobility function of each patient.
Our study has several limitations. First, we excluded patients with severe comorbidities from the study. Therefore, the current data should be considered as information conceived from typical clinical cases of KOA. In cases with severe comorbidities, the score of the LS risk test would be influenced by conditions other than those affecting the bones and joints and would need to be interpreted more cautiously. Second, since the minimum clinically important difference (MCID) of the LS risk test has not been established, the efficacy of treatment in each case cannot be determined. Further studies are required to determine the MCID to identify the factors that may have an impact on the efficacy of treatment. Finally, a fraction of patients was lost to follow-up. The lower score observed in the two-step test in the lost to follow-up group suggests the possibility that patients who had poor mobility after surgery could not turn up for the follow-ups. As this is an inherent limitation in longitudinal studies related to mobility disorders, an alternative method of data collection from patients who have restricted mobility is required in future studies.